Tommie Reerink

Stock Analyst at Goldman Sachs

(1.39)
# 3,149
Out of 4,670 analysts
3
Total ratings
66.67%
Success rate
-8.39%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Tommie Reerink

Atara Biotherapeutics
Jul 17, 2024
Maintains: Sell
Price Target: $13$11
Current: $11.47
Upside: -4.10%